Previous close | 108.60 |
Open | 108.35 |
Bid | 107.40 x 0 |
Ask | 108.05 x 0 |
Day's range | 108.35 - 108.35 |
52-week range | 86.98 - 122.45 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 22 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Robust demand for Alexandria's (ARE) high-quality life science and lab office properties in key markets, healthy operating performance and expansion efforts bode well for long-term growth.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that it has released its 2023 Corporate Responsibility Report, reinforcing the company's longstanding operational excellence across its industry-leading, differentiated Labspace® platform. At the vanguard and heart of the life science industry for over 30 years, Alexa
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.